You are here: Industry Insights > COVID-19

News List

How the AMR Action Fund intends to support antibiotic-focused biotechs expresspharma
July 24, 2020
While focus is on the global deaths from COVID-19 crossing the six lakh mark, we have lost seven lakh people to antimicrobial resistance (AMR) each year, which is why more than 20 biopharmaceutical companies recently announced the launch of the AMR ...
Pharma experts feel more drugs need price increase expresspharma
July 24, 2020
Recently, NPPA allowed 50 per cent price increase for heparin injection, which is also an essential medicine for the treatment of COVID-19 patients.
U.S. Inks $2B COVID-19 Vax Deal with Pfizer, BioNTech contractpharma
July 24, 2020
U.S. government placed an initial order of 100 million doses and can acquire up to 500 million additional doses.
Company Implements LabVantage COVID-19 LIMS Solution contractpharma
July 24, 2020
?LabVantage Solutions Inc. has announced that a Fortune 100 global consumer packaged goods (CPG) company has deployed its COVID-19 LIMS solution to ensure employee health and safety in the workplace.
Neutralizing antibodies isolated from COVID-19 patients may suppress virus worldpharmanews
July 23, 2020
Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus.
10x Genomics Launches Immune Profiling Product to Combat COVID-19 americanpharmaceuticalreview
July 23, 2020
10x Genomics has launched its Chromium Single Cell Immune Profiling v2 product. The new product extends the capabilities of the original version, supporting breakthroughs in immunology, oncology, autoimmunity, inflammation, transplant biology, and ...
Hackensack Meridian CDI, Merck Announce COVID-19 Research Collaboration americanpharmaceuticalreview
July 23, 2020
The Hackensack Meridian Center for Discovery and Innovation (CDI) has announced a research collaboration with Merck to investigate drugs for treating COVID-19.
Akebia Begins Investigator-Sponsored Vadadustat Study for ARDS in COVID-19 americanpharmaceuticalreview
July 23, 2020
Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat, Akebia's investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a potential therapy to prevent and ...
Japan approves dexamethasone to treat Covid-19 patients pharmaceutical-technology
July 23, 2020
The Japanese health ministry has approved a low-cost and widely available steroid drug, dexamethasone, for the treatment of patients suffering from Covid-19.
Piramal Critical Care partners with Medivant Healthcare to provide injectable drugs in the US expresspharma
July 23, 2020
Through this partnership, PCC and Medivant Healthcare will work together to distribute single-dose injectable drugs in approved states for COVID-19 patients that have fallen dangerously short in supply.